Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Outcomes and Cost-effectiveness Analysis of ShapeMatch Technology

This study has suspended participant recruitment.
(FDA recall - Canadian system did voluntary suspension of study)
Sponsor:
Collaborator:
Stryker Canada LP
Information provided by (Responsible Party):
Lauren Beaupre, University of Alberta
ClinicalTrials.gov Identifier:
NCT01483066
First received: November 25, 2011
Last updated: December 22, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)